Revisiting post-infectious glomerulonephritis in the emerging era of C3 glomerulopathy

Background Post-infectious glomerulonephritis (PIGN) is an immune complex-mediated glomerular injury that typically resolves. Dominant C3 deposition is characteristic of PIGN, but with the emergence of C3 glomerulonephritis (C3GN) as a distinct entity, it is unclear how the pathologic similarities between PIGN and C3GN should be reconciled. Therefore, nephrologists and nephropathologists need additional guidance at the time of biopsy. Methods We studied 23 pediatric and young adult patients diagnosed with PIGN. Patients were divided into two groups, one with co-dominance between C3 and immunoglobulins and the other meeting proposed diagnostic criteria for C3GN. Clinical and pathological features were compared. Results No clinical and/or pathological features could distinguish between those with C3-co-dominant deposits and those with C3 dominance. Nearly all patients in both groups regained their baseline renal function without clinical intervention. Conclusions Although the identification of abnormalities of the alternative pathway of complement is characteristic of C3GN, testing is not widely available and the turnaround time often exceeds 1 month. Our study found that PIGN with either co-dominant or dominant C3 deposition in a cohort of young patients has excellent short-term outcomes. Close clinical observation for persistent abnormalities, such as hypocomplementemia, prolonged hematuria or proteinuria, is recommended to single out patients that may harbor intrinsic complement abnormalities.

[1]  K. Nath,et al.  Kidney Disease Caused by Dysregulation of the Complement Alternative Pathway: An Etiologic Approach. , 2015, Journal of the American Society of Nephrology : JASN.

[2]  P. O'kelly,et al.  C3 glomerulopathy: clinicopathologic features and predictors of outcome. , 2014, Clinical journal of the American Society of Nephrology : CJASN.

[3]  S. Nasr,et al.  Atypical Postinfectious Glomerulonephritis Is Associated with Abnormalities in the Alternative Pathway of Complement , 2014 .

[4]  V. D’Agati,et al.  Toward a working definition of C3 glomerulopathy by immunofluorescence. , 2014, Kidney international.

[5]  Richard J. H. Smith,et al.  Streptococcal infection as possible trigger for dense deposit disease (C3 glomerulopathy) , 2014, European Journal of Pediatrics.

[6]  V. D’Agati,et al.  C3 glomerulopathy: consensus report , 2013, Kidney international.

[7]  B. Ranchin,et al.  C3 nephritic factor associated with C3 glomerulopathy in children , 2013, Pediatric Nephrology.

[8]  G. Markowitz,et al.  C3 glomerulopathy masquerading as acute postinfectious glomerulonephritis. , 2012, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[9]  S. Nasr,et al.  C3 Glomerulonephritis: Clinicopathologic findings, complement abnormalities, glomerular proteomic profile, treatment and follow-up , 2012, Kidney international.

[10]  T. Aitman,et al.  Acute Presentation and Persistent Glomerulonephritis Following Streptococcal Infection in a Patient With Heterozygous Complement Factor H–Related Protein 5 Deficiency , 2012, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[11]  Richard J. H. Smith,et al.  Membranoproliferative glomerulonephritis and C3 glomerulopathy: resolving the confusion. , 2012, Kidney international.

[12]  E. Kitano,et al.  A case of dense deposit disease associated with a group A streptococcal infection without the involvement of C3NeF or complement factor H deficiency , 2010, Pediatric Nephrology.

[13]  H. Kitamura,et al.  A prolonged course of Group A streptococcus-associated nephritis: a mild case of dense deposit disease (DDD)? , 2009, Clinical nephrology.

[14]  A. Pönkä,et al.  Mycoplasmal Pneumonia Associated with Mesangiocapillary Glomerulonephiritis Type II (Dense Deposit Disease) , 2009 .

[15]  V. D’Agati,et al.  Dense deposit disease: clinicopathologic study of 32 pediatric and adult patients. , 2009, Clinical journal of the American Society of Nephrology : CJASN.

[16]  V. D’Agati,et al.  Acute Postinfectious Glomerulonephritis in the Modern Era: Experience With 86 Adults and Review of the Literature , 2008, Medicine.

[17]  G. Filler,et al.  Prevalence of complications in children with chronic kidney disease according to KDOQI. , 2006, Kidney international.

[18]  F. Sotsiou Postinfectious glomerulonephritis. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[19]  M. Kazatchkine,et al.  Hypocomplementaemia of poststreptococcal acute glomerulonephritis is associated with C3 nephritic factor (C3NeF) IgG autoantibody activity. , 1994, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[20]  A. Pönkä,et al.  Mycoplasmal pneumonia associated with mesangiocapillary glomerulonephritis type II (dense deposit disease). , 1984, Acta medica Scandinavica.

[21]  W. Thoenes,et al.  Subtypes of acute postinfectious glomerulonephritis. Synopsis of clinical and pathological features. , 1982, Clinical nephrology.